The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia

Cited by (1,513)

Items 201–300 of 1,513

  1. The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
    Kent, Sarah A., Spires-Jones, Tara L., Durrant, Claire S. · 2020 · Acta Neuropathologica
  2. Combined Prevalence of Frailty and Mild Cognitive Impairment in a Population of Elderly Japanese People
    Hiroyuki Shimada, Hyuma Makizako, Takehiko Doi, Daisuke Yoshida, Kota Tsutsumimoto, Yuya Anan, Kazuki Uemura, Tadashi Ito, Sangyoon Lee, Hyuntae Park et al. · 2013 · Journal of the American Medical Directors Association
  3. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
    Bacioglu, Mehtap, Maia, Luis F., Preische, Oliver, Schelle, Juliane, Apel, Anja, Kaeser, Stephan A., Schweighauser, Manuel, Eninger, Timo, Lambert, Marius, Pilotto, Andrea et al. · 2016 · Neuron
  4. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
    Victor L. Villemagne, Vincent Doré, Samantha C. Burnham, Colin Louis Masters, Christopher Cleon Rowe · 2018 · Nature Reviews Neurology
  5. Postoperative Cognitive Dysfunction and Noncardiac Surgery
    Lisbeth Anne Evered, BRENDAN S. SILBERT · 2018 · Anesthesia & Analgesia
  6. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
    Villeneuve, Sylvia, Rabinovici, Gil D., Cohn-Sheehy, Brendan I., Madison, Cindee, Ayakta, Nagehan, Ghosh, Pia M., La Joie, Renaud, Arthur-Bentil, Samia Kate, Vogel, Jacob W., Marks, Shawn M. et al. · 2015 · Brain
  7. Exercise plasma boosts memory and dampens brain inflammation via clusterin
    De Miguel, Zurine, Khoury, Nathalie, Betley, Michael J., Lehallier, Benoit, Willoughby, Drew, Olsson, Niclas, Yang, Andrew C., Hahn, Oliver, Lu, Nannan, Vest, Ryan T. et al. · 2021 · Nature
  8. Resting‐state network dysfunction in Alzheimer's disease: A systematic review and meta‐analysis
    AmanPreet Badhwar, Angela Tam, Christian L. Dansereau, Pierre Orban, Felix Hoffstaedter, Pierre Bellec · 2017 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  9. Diagnosis of Cerebral Amyloid Angiopathy
    Steven Mark Greenberg, Andreas Charidimou · 2018 · Stroke
  10. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease
    Janelidze, Shorena, Stomrud, Erik, Smith, Ruben, Palmqvist, Sebastian, Mattsson, Niklas, Airey, David C., Proctor, Nicholas K., Chai, Xiyun, Shcherbinin, Sergey, Sims, John R. et al. · 2020 · Nature Communications
  11. Alzheimer’s Disease
    Vanessa de Jesus Rodrigues de Paula, Márcia Radanovic, Breno Satler Diniz, Orestes Vicente Forlenza · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  12. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis
    Santos, Cláudia Y., Snyder, Peter J., Wu, Wen‐Chih, Zhang, Mia, Echeverria, Ana, Alber, Jessica · 2017 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
  13. Hearing Loss and Depression in Older Adults: A Systematic Review and Meta-analysis
    Blake J. Lawrence, Dona M. P. Jayakody, Rebecca J. Bennett, Robert Henry Eikelboom, Natalie Gasson, Peter Leon Friedland · 2019 · The Gerontologist
  14. Deep learning to detect Alzheimer's disease from neuroimaging: A systematic literature review
    Amir Ebrahimi Ghahnavieh, Suhuai Luo, Raymond Chiong · 2019 · Computer Methods and Programs in Biomedicine
  15. Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
    Qiuyang Zheng, Xin Wang · 2024 · Protein & Cell
  16. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia
    Rosebud O. Roberts, Teresa J. H. Christianson, Walter K. Kremers, Michelle M. Mielke, Mary M. Machulda, Maria E. Vassilaki, Rabe E. Alhurani, Yonas E. Geda, David S. Knopman, Ronald Carl Petersen · 2015 · JAMA Neurology
  17. Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: a systematic review of epidemiologic research
    Power, Melinda C., Adar, Sara D., Yanosky, Jeff D., Weuve, Jennifer · 2016 · NeuroToxicology
  18. Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia
    Slot, Rosalinde E.R., Sikkes, Sietske A.M., Berkhof, Johannes, Brodaty, Henry, Buckley, Rachel, Cavedo, Enrica, Dardiotis, Efthimios, Guillo‐Benarous, Francoise, Hampel, Harald, Kochan, Nicole A. et al. · 2019 · Alzheimer's & Dementia
  19. Olfactory and other sensory impairments in Alzheimer disease
    Murphy, Claire · 2019 · Nature Reviews Neurology
  20. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States
    Brookmeyer, Ron, Abdalla, Nada, Kawas, Claudia H., Corrada, María M. · 2018 · Alzheimer's & Dementia
  21. Regional profiles of the candidate tau PET ligand <sup>18</sup> F-AV-1451 recapitulate key features of Braak histopathological stages
    Schwarz, Adam J., Yu, Peng, Miller, Bradley B., Shcherbinin, Sergey, Dickson, James, Navitsky, Michael, Joshi, Abhinay D., Devous, Michael D., Mintun, Mark S. · 2016 · Brain
  22. Postoperative cognitive dysfunction and dementia: what we need to know and do
    Matthew J. Needham, C.E. Webb, Daniele C. Bryden · 2017 · British Journal of Anaesthesia
  23. Multimodal deep learning for Alzheimer's disease dementia assessment
    Qiu, Shangran, Miller, Matthew I., Joshi, Prajakta S., Lee, Joyce C., Xue, Chonghua, Ni, Yunruo, Wang, Yuwei, De Anda-Duran, Ileana, Hwang, Phillip H., Cramer, Justin A. et al. · 2022 · Nature Communications
  24. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease
    Willette, Auriel A., Bendlin, Barbara B., Starks, Erika J., Birdsill, Alex C., Johnson, Sterling C., Christian, Bradley T., Okonkwo, Ozioma C., La Rue, Asenath, Hermann, Bruce P., Koscik, Rebecca L. et al. · 2015 · JAMA Neurology
  25. Drug development in Alzheimer’s disease: the path to 2025
    Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip · 2016 · Alzheimer's Research &amp; Therapy
  26. Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
    Palmqvist, Sebastian, Mattsson, Niklas, Hansson, Oskar, for the Alzheimer’s Disease Neuroimaging Initiative · 2016 · Brain
  27. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts
    Calvin C. Willhite, Nataliya A. Karyakina, Robert A. Yokel, Nagarajkumar Yenugadhati, Thomas Wısnıewskı, Ian M. F. Arnold, Franco Momoli, Daniel R. Krewski · 2014 · Critical Reviews in Toxicology
  28. A clinicopathological approach to the diagnosis of dementia
    Fanny M. Elahi, Bruce L. Miller · 2017 · Nature Reviews Neurology
  29. Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies
    Tromp, D., Dufour, A., Lithfous, S., Pebayle, T., Després, O. · 2015 · Ageing Research Reviews
  30. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
    Higginbotham, Lenora, Ping, Lingyan, Dammer, Eric B., Duong, Duc M., Zhou, Maotian, Gearing, Marla, Hurst, Cheyenne, Glass, Jonathan D., Factor, Stewart A., Johnson, Erik C. B. et al. · 2020 · Science Advances
  31. Predicting alzheimer’s disease progression using multi-modal deep learning approach
    Lee, Garam, Nho, Kwangsik, Kang, Byungkon, Sohn, Kyung-Ah, Kim, Dokyoon, for Alzheimer’s Disease Neuroimaging Initiative, Weiner, Michael W., Aisen, Paul, Petersen, Ronald, Jack, Clifford R. et al. · 2019 · Scientific Reports
  32. Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial
    Sink, Kaycee M., Espeland, Mark A., Castro, Cynthia M., Church, Timothy, Cohen, Ron, Dodson, John A., Guralnik, Jack, Hendrie, Hugh C., Jennings, Janine, Katula, Jeffery et al. · 2015 · JAMA
  33. α-synuclein in the pathophysiology of Alzheimer’s disease
    Twohig, Daniel, Nielsen, Henrietta M. · 2019 · Molecular Neurodegeneration
  34. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β‐amyloid
    Landau, Susan M., Lu, Ming, Joshi, Abhinay D., Pontecorvo, Michael, Mintun, Mark A., Trojanowski, John Q., Shaw, Leslie M., Jagust, William J., for the Alzheimer's Disease Neuroimaging Initiative · 2013 · Annals of Neurology
  35. Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
    Vos, Stephanie J. B., Verhey, Frans, Frölich, Lutz, Kornhuber, Johannes, Wiltfang, Jens, Maier, Wolfgang, Peters, Oliver, Rüther, Eckart, Nobili, Flavio, Morbelli, Silvia et al. · 2015 · Brain
  36. Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia
    La Joie, Renaud, Perrotin, Audrey, Barré, Louisa, Hommet, Caroline, Mézenge, Florence, Ibazizene, Méziane, Camus, Vincent, Abbas, Ahmed, Landeau, Brigitte, Guilloteau, Denis et al. · 2012 · The Journal of Neuroscience
  37. Optimizing Patient Care and Research: The Amsterdam Dementia Cohort
    Wiesje M. van der Flier, Yolande A.L. Pijnenburg, Niels D. Prins, Afina Willemina Lemstra, Femke H. Bouwman, Charlotte Elisabeth Teunissen, Bart N.M. van Berckel, Cornelis Jan Stam, Frederik Barkhof, Pieter Jelle Visser et al. · 2014 · Journal of Alzheimer s Disease
  38. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging
    David R. Roalf, Paul J. Moberg, Sharon Xiangwen Xie, David A. Wolk, Stephen T. Moelter, Steven Edward Arnold · 2012 · Alzheimer s & Dementia
  39. Cognitive function in patients with diabetes mellitus: guidance for daily care
    Paula S. Koekkoek, Laurens Jaap Kappelle, Esther van den Berg, Guy E.H.M. Rutten, Geert Jan Biessels · 2015 · The Lancet Neurology
  40. Apolipoprotein E in Alzheimer's Disease: An Update
    Yu, Jin-Tai, Tan, Lan, Hardy, John · 2014 · Annual Review of Neuroscience
  41. Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
    David S. Knopman, Ronald Carl Petersen · 2014 · Mayo Clinic Proceedings
  42. Mechanisms of cognitive dysfunction in CKD
    Viggiano, Davide, Wagner, Carsten A., Martino, Gianvito, Nedergaard, Maiken, Zoccali, Carmine, Unwin, Robert, Capasso, Giovambattista · 2020 · Nature Reviews Nephrology
  43. Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
    Abhinay D. Joshi, Michael J. Pontecorvo, Chrisopher M. Clark, Alan P. Carpenter, Danna L. Jennings, Carl Sadowsky, Lee P. Adler, Karel D. Kovnat, John Peter Seibyl, Anupa Arora et al. · 2012 · Journal of Nuclear Medicine
  44. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
    Lindestam Arlehamn, Cecilia S., Dhanwani, Rekha, Pham, John, Kuan, Rebecca, Frazier, April, Rezende Dutra, Juliana, Phillips, Elizabeth, Mallal, Simon, Roederer, Mario, Marder, Karen S. et al. · 2020 · Nature Communications
  45. Association of midlife to late-life blood pressure patterns with incident dementia
    Walker, Keenan A., Sharrett, A. Richey, Wu, Aozhou, Schneider, Andrea L. C., Albert, Marilyn, Lutsey, Pamela L., Bandeen-Roche, Karen, Coresh, Josef, Gross, Alden L., Windham, B. Gwen et al. · 2019 · JAMA
  46. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
    Geda, Yonas E., Schneider, Lon S., Gitlin, Laura N., Miller, David S., Smith, Gwenn S., Bell, Joanne, Evans, Jovier, Lee, Michael, Porsteinsson, Anton, Lanctôt, Krista L. et al. · 2013 · Alzheimer's &amp; Dementia
  47. Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
    Lam, Benjamin, Masellis, Mario, Freedman, Morris, Stuss, Donald T, Black, Sandra E · 2013 · Alzheimer's Research &amp; Therapy
  48. Distinguishing Alzheimer’s disease from other major forms of dementia
    Karantzoulis, Stella, Galvin, James E · 2011 · Expert Review of Neurotherapeutics
  49. Ozone, Particulate Matter, and Newly Diagnosed Alzheimer's Disease: A Population-Based Cohort Study in Taiwan
    Jung, Chau-Ren, Lin, Yu-Ting, Hwang, Bing-Fang · 2015 · Journal of Alzheimer's Disease
  50. Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment
    Alzheimer’s Disease Neuroimaging Initiative, Avinash Chandra, George Dervenoulas, Marios Politis · 2018 · Journal of Neurology
  51. CSF biomarker variability in the Alzheimer's Association quality control program
    Niklas Mattsson, Ulf Andréasson, Staffan Persson, María C. Carrillo, Steven John Collins, Sonia Chalbot, Neal E. Cutler, Diane Dufour‐Rainfray, Anne M. Fagan, Niels H. H. Heegaard et al. · 2013 · Alzheimer s & Dementia
  52. Dementia in Down syndrome: unique insights for Alzheimer disease research
    Lott, Ira T., Head, Elizabeth · 2019 · Nature Reviews Neurology
  53. Brain PET in the Diagnosis of Alzheimer’s Disease
    Charles V. Marcus, Esther Mena, Rathan M. Subramaniam · 2014 · Clinical Nuclear Medicine
  54. Systematic Review on Resting-State EEG for Alzheimer’s Disease Diagnosis and Progression Assessment
    Raymundo Cassani, Mar Estarellas, Rodrigo San-Martin, Francisco J. Fraga, Tiago Henrique Falk · 2018 · Disease Markers
  55. Impairments of neural circuit function in Alzheimer's disease
    Busche, Marc Aurel, Konnerth, Arthur · 2016 · Philosophical Transactions of the Royal Society B: Biological Sciences
  56. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
    Janelidze, Shorena, Mattsson, Niklas, Stomrud, Erik, Lindberg, Olof, Palmqvist, Sebastian, Zetterberg, Henrik, Blennow, Kaj, Hansson, Oskar · 2018 · Neurology
  57. Concordance between the assessment of Aβ42, T‐tau, and P‐T181‐tau in peripheral blood neuronal‐derived exosomes and cerebrospinal fluid
    Longfei Jia, Qiongqiong Qiu, Heng Zhang, Lan Chu, Yifeng Du, Jiewen Zhang, Chunkui Zhou, Furu Liang, Shengliang Shi, Shan Wang et al. · 2019 · Alzheimer s & Dementia
  58. Clinical subtypes of chronic traumatic encephalopathy: Literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome
    Montenigro, Philip H, Baugh, Christine M, Daneshvar, Daniel H, Mez, Jesse, Budson, Andrew E, Au, Rhoda, Katz, Douglas I, Cantu, Robert C, Stern, Robert A · 2014 · Alzheimer's Research &amp; Therapy
  59. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid
    Bittner, Tobias, Zetterberg, Henrik, Teunissen, Charlotte E., Ostlund, Richard E., Militello, Michael, Andreasson, Ulf, Hubeek, Isabelle, Gibson, David, Chu, David C., Eichenlaub, Udo et al. · 2016 · Alzheimer's &amp; Dementia
  60. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
    Palmqvist, Sebastian, Zetterberg, Henrik, Mattsson, Niklas, Johansson, Per, For the Alzheimer's Disease Neuroimaging Initiative, Minthon, Lennart, Blennow, Kaj, Olsson, Mattias, For the Swedish BioFINDER study group, Hansson, Oskar et al. · 2015 · Neurology
  61. Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
    Oeckl, Patrick, Halbgebauer, Steffen, Anderl-Straub, Sarah, Steinacker, Petra, Huss, André M., Neugebauer, Hermann, von Arnim, Christine A.F., Diehl-Schmid, Janine, Grimmer, Timo, Kornhuber, Johannes et al. · 2019 · Journal of Alzheimer’s Disease
  62. Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
    Brickman, Adam M., Manly, Jennifer J., Honig, Lawrence S., Sanchez, Danurys, Reyes‐Dumeyer, Dolly, Lantigua, Rafael A., Lao, Patrick J., Stern, Yaakov, Vonsattel, Jean Paul, Teich, Andrew F. et al. · 2021 · Alzheimer's &amp; Dementia
  63. How Can Hearing Loss Cause Dementia?
    Timothy David Griffiths, Meher Lad, Sukhbinder Kumar, Emma Holmes, Bob McMurray, Eleanor A. Maguire, Alexander J. Billig, William Sedley · 2020 · Neuron
  64. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
    Rezai, Ali R., Ranjan, Manish, D’Haese, Pierre-François, Haut, Marc W., Carpenter, Jeffrey, Najib, Umer, Mehta, Rashi I., Chazen, J. Levi, Zibly, Zion, Yates, Jennifer R. et al. · 2020 · Proceedings of the National Academy of Sciences
  65. Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease
    Robin de Florès, Renaud La Joie, Gaël Chételat · 2015 · Neuroscience
  66. ESPEN guidelines on nutrition in dementia
    Volkert, Dorothee, Chourdakis, Michael, Faxen-Irving, Gerd, Frühwald, Thomas, Landi, Francesco, Suominen, Merja H., Vandewoude, Maurits, Wirth, Rainer, Schneider, Stéphane M. · 2015 · Clinical Nutrition
  67. Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
    Aura L. Ferreiro, JooHee Choi, Jian Ryou, Erin P. Newcomer, Regina Thompson, Rebecca M. Bollinger, Carla M. Hall-Moore, I. Malick Ndao, Laurie Sax, Tammie L.S. Benzinger et al. · 2023 · Science Translational Medicine
  68. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
    Kashiwaya, Yoshihiro, Bergman, Christian, Lee, Jong-Hwan, Wan, Ruiqian, King, M. Todd, Mughal, Mohamed R., Okun, Eitan, Clarke, Kieran, Mattson, Mark P., Veech, Richard L. · 2013 · Neurobiology of Aging
  69. Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms
    Claudio Babiloni, Roberta Lizio, Nicola Marzano, Paolo Capotosto, Andrea Soricelli, Antonio Ivano Triggiani, Susanna Cordone, Loreto Gesualdo, Claudio Del Percio · 2015 · International Journal of Psychophysiology
  70. Contribution of Alzheimer disease to mortality in the United States
    Bryan David James, Sue E. Leurgans, Liesi E. Hebert, Paul A. Scherr, Kristine S. Yaffe, David Alan Bennett · 2014 · Neurology
  71. From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices
    Pei Li, Gunhee Lee, Su Yeong Kim, Se Young Kwon, Hyung‐Ryong Kim, Steve Park · 2021 · ACS Nano
  72. Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update
    del Campo, Marta, Mollenhauer, Brit, Bertolotto, Antonio, Engelborghs, Sebastiaan, Hampel, Harald, Simonsen, Anja Hviid, Kapaki, Elisabeth, Kruse, Niels, Le Bastard, Nathalie, Lehmann, Sylvain et al. · 2012 · Biomarkers in Medicine
  73. Spectral-Domain OCT Measurements in Alzheimer’s Disease
    Victor T.T. Chan, Zihan Sun, Shumin Tang, Li Jia Chen, Adrian Wong, Clement Chee Yung Tham, Tien Yin Wong, Christopher Chen, M. Kamran Ikram, Heather Elizabeth Whitson et al. · 2018 · Ophthalmology
  74. Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge
    Bron, Esther E., Smits, Marion, van der Flier, Wiesje M., Vrenken, Hugo, Barkhof, Frederik, Scheltens, Philip, Papma, Janne M., Steketee, Rebecca M.E., Méndez Orellana, Carolina, Meijboom, Rozanna et al. · 2015 · NeuroImage
  75. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
    Vanderstichele, Hugo, Bibl, Mirko, Engelborghs, Sebastiaan, Le Bastard, Nathalie, Lewczuk, Piotr, Molinuevo, Jose Luis, Parnetti, Lucilla, Perret‐Liaudet, Armand, Shaw, Leslie M., Teunissen, Charlotte et al. · 2012 · Alzheimer's &amp; Dementia
  76. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
    Hampel, Harald, Caraci, Filippo, Cuello, A. Claudio, Caruso, Giuseppe, Nisticò, Robert, Corbo, Massimo, Baldacci, Filippo, Toschi, Nicola, Garaci, Francesco, Chiesa, Patrizia A. et al. · 2020 · Frontiers in Immunology
  77. The Pivotal Role of Semantic Memory in Remembering the Past and Imagining the Future
    Irish, Muireann, Piguet, Olivier · 2013 · Frontiers in Behavioral Neuroscience
  78. Pathology and pathogenesis of vascular cognitive impairment—a critical update
    Jellinger, Kurt A. · 2013 · Frontiers in Aging Neuroscience
  79. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
    John Tiernan O'Brien, Clive Holmes, Matthew S. Jones, Roy W. Jones, Gill Livingston, Ian Grant McKeith, Peter J. Mittler, Peter Passmore, Craig William Ritchie, Louise A. Robinson et al. · 2017 · Journal of Psychopharmacology
  80. Consensus guidelines for lumbar puncture in patients with neurological diseases
    Sebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, Kaj Blennow, Raf Brouns, Manuel Comabella, Irena Dujmović, Wiesje M. van der Flier, Lutz Frölich, Daniela Galimberti et al. · 2017 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  81. The clinical spectrum of sport-related traumatic brain injury
    Jordan, Barry D. · 2013 · Nature Reviews Neurology
  82. Why musical memory can be preserved in advanced Alzheimer’s disease
    Jörn-Henrik Jacobsen, Johannes Stelzer, Thomas Hans Fritz, Gaël Chételat, Renaud La Joie, Robert Turner · 2015 · Brain
  83. Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
    Claudio Liguori, Andrea Romigi, Marzia Nuccetelli, Silvana Zannino, Giuseppe Sancesario, Alessandro Martorana, Maria Albanese, Nicola Biagio Mercuri, Francesca Izzi, Sergio Bernardini et al. · 2014 · JAMA Neurology
  84. Alzheimer’s Disease In African Americans: Risk Factors And Challenges For The Future
    Lisa Laverne Barnes, David Alan Bennett · 2014 · Health Affairs
  85. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
    Gaël Chételat, Renaud La Joie, Nicolas Villain, Audrey Perrotin, Vincent de La Sayette, Francis Eustache, Rik R. Vandenberghe · 2013 · NeuroImage Clinical
  86. Blood‐based biomarkers for Alzheimer's disease
    Antoine Leuzy, Niklas Mattsson, Sebastian Palmqvist, Shorena Janelidze, Jeffrey L. Dage, Oskar Hansson · 2021 · EMBO Molecular Medicine
  87. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
    Ewers, Michael, Franzmeier, Nicolai, Suárez-Calvet, Marc, Morenas-Rodriguez, Estrella, Caballero, Miguel Angel Araque, Kleinberger, Gernot, Piccio, Laura, Cruchaga, Carlos, Deming, Yuetiva, Dichgans, Martin et al. · 2019 · Science Translational Medicine
  88. Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review
    Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone, Bruno Pietro Imbimbo, Vincenzo Valiani, Pasquale Agosti, Andrea Schilardi, Alessia D’Introno, Maddalena La Montagna, M. Calvani et al. · 2017 · Journal of Alzheimer s Disease
  89. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease
    Natalia M. Lyra e Silva, Rafaella Araujo Gonçalves, Tharick Ali Pascoal, Ricardo A. S. Lima‐Filho, Elisa de Paula França Resende, Érica Leandro Marciano Vieira, Antônio Lúcio Teixeira, Leonardo Cruz de Souza, Julyanna A. Peny, Juliana T.S. Fortuna et al. · 2021 · Translational Psychiatry
  90. Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
    Lantero Rodriguez, Juan, Karikari, Thomas K., Suárez-Calvet, Marc, Troakes, Claire, King, Andrew, Emersic, Andreja, Aarsland, Dag, Hye, Abdul, Zetterberg, Henrik, Blennow, Kaj et al. · 2020 · Acta Neuropathologica
  91. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease
    Kreisl, William C., Lyoo, Chul Hyoung, McGwier, Meghan, Snow, Joseph, Jenko, Kimberly J., Kimura, Nobuyo, Corona, Winston, Morse, Cheryl L., Zoghbi, Sami S., Pike, Victor W. et al. · 2013 · Brain
  92. Genetics of dementia
    Loy, Clement T, Schofield, Peter R, Turner, Anne M, Kwok, John BJ · 2014 · The Lancet
  93. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
    Weiner, Michael W., Veitch, Dallas P., Aisen, Paul S., Beckett, Laurel A., Cairns, Nigel J., Cedarbaum, Jesse, Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William et al. · 2015 · Alzheimer's &amp; Dementia
  94. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
    Michael Ewers, Reisa Anne Sperling, William Edward Klunk, Michael Walter Weiner, Harald Juergen Hampel · 2011 · Trends in Neurosciences
  95. Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
    for the Alzheimer’s Disease Neuroimaging Initiative, Suárez-Calvet, Marc, Morenas-Rodríguez, Estrella, Kleinberger, Gernot, Schlepckow, Kai, Araque Caballero, Miguel Ángel, Franzmeier, Nicolai, Capell, Anja, Fellerer, Katrin, Nuscher, Brigitte et al. · 2019 · Molecular Neurodegeneration
  96. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
    Douglas I. Katz, Charles B. Bernick, David W. Dodick, Jesse B Mez, Megan L. Mariani, Charles H. Adler, Michael Louis Alosco, Laura Joan Balcer, Sarah Jane Banks, William Barr et al. · 2021 · Neurology
  97. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
    DemGene, Steinberg, Stacy, Stefansson, Hreinn, Jonsson, Thorlakur, Johannsdottir, Hrefna, Ingason, Andres, Helgason, Hannes, Sulem, Patrick, Magnusson, Olafur Th, Gudjonsson, Sigurjon A et al. · 2015 · Nature Genetics
  98. Connected speech and language in mild cognitive impairment and Alzheimer’s disease: A review of picture description tasks
    Mueller, Kimberly D., Hermann, Bruce, Mecollari, Jonilda, Turkstra, Lyn S. · 2018 · Journal of Clinical and Experimental Neuropsychology
  99. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
    Mummery, Catherine J., Börjesson-Hanson, Anne, Blackburn, Daniel J., Vijverberg, Everard G. B., De Deyn, Peter Paul, Ducharme, Simon, Jonsson, Michael, Schneider, Anja, Rinne, Juha O., Ludolph, Albert C. et al. · 2023 · Nature Medicine
  100. Cognitive training for people with mild to moderate dementia
    Bahar-Fuchs, Alex, Martyr, Anthony, Goh, Anita MY, Sabates, Julieta, Clare, Linda · 2019 · Cochrane Database of Systematic Reviews